Stanford Social Innovation Review Podcast

Two megatrends are locking in: Massive incentive change and information liberation, says Todd Park, CTO of the US Department of Health and Human Services. The federal programs must lead the way in changing from fee-for-service to incentives for value in healthcare. Medicare, Medicaid, and the Veteran’s Administration represent the largest repository of public health data in the world. More information about the public health, stripped of personal identification, is being made available so that innovators can use it to learn more about public health, and create health-maximizing options. Private insurers adopt the same pay structure as the federal programs, therefore, HHS must be the one to initiate more efficient means of delivering, and charging for, health value. Park identifies three parts to data liberation in the health care industry: 1) Patient data liquidity—including making records available to the patients themselves; 2) market transparency—listing benefits and pricing of every public and private insurance plan available in the U.S. through healthcare.gov; and 3) a health data initiative to let people know what data is available on the population at large, and releasing it for anyone’s use. Some private innovations from this data release include Asthmapolis, which helps people control their asthma, and iTriage. Coordination of service, identification of gaps, methods of efficiency developed in industries outside of health care need to be brought in to rework the healthcare industry, according to Park.https://ssir.org/podcasts/entry/todd_park_changing_behavior_and_changing_policies_panel_part_3

It was a bit of a shake-up in February 2010 when the Quadrennial Defense Review of the DoD listed resource scarcity and climate change as primary threats to global security. Now the defense sector is rolling out means of planning, strategizing, and reducing the use of resources. In many cases, what’s good for the environment also cuts costs and streamlines activities. Daniel Kreeger, Executive Director of the Association of Climate Change Officers (ACCO) outlines the relatively new position of “Climate Change Officer.” In a recent carbon disclosure project, professionals concerned with climate management came from as many as eleven different organization silos, from supply-chain management to public relations. Where many functions have been traditionally the provenance of one officer, and a commander’s term averages two years, coordination locally and across forces is smoothing the way and building awareness of sustainability issues. The Army and Navy are establishing environmental policies and establishing scoring and benchmarks. Kreeger points out the DoD has traditionally been a test bed and market maker for many technologies, including flat screens, GPS, fiber optic communications, and even the internet. Innovations in green technology will undoubtedly follow.https://ssir.org/podcasts/entry/daniel_kreeger_edf_future_of_green_calls

From solar shingles to locally implemented environmental waste collection, companies are creating products and corporate infrastructures that are about more than just profit. Aron Cramer, an advisor on corporate responsibility, points out several benefits in the revolution in this open-call conversation. He explains the need to bridge the gap between businesses for profit and nonprofit organizations, and how any working combination of the two would bring about social change, environmental improvements, and technological innovations. This open phone call challenges the stereotypes of business and philanthropy, as well the degree of separation between the two sectors. Cramer explains that a synthesis between the two, with an emphasis on the results-based movement of corporations and the socially-based goals of nonprofit organizations, would create investment in small businesses and corporate-social responsibility. Impact investing, social entrepreneurs, and locally-based businesses are part of a newly growing trend that supports local and international social goals, environmental awareness, and minimization of poverty. This trend, Aron Cramer proves through several examples and in answers to callers’ question, is making the world better, and will continue to improve environmental and social standards as businesses and non-profits continue to merge and cooperate.https://ssir.org/podcasts/entry/aron_cramer_sustainable_excellence_the_future_of_business_in_a_fast_changin

As an executive with UnitedHealth Group, Richard Migliori is responsible for ensuring clinical excellence and linking that excellence to practical clinical outcomes and robust business results. In this university podcast, he talks about innovation as the lifeblood of his organization, and the criteria by which innovative efforts are adopted. He emphasizes the need for the healthcare system to become more connected, intelligent, and aligned in order to be sustainable in the long-term. Migliori spoke at the 2011 GSB Healthcare Summit, sponsored by the Stanford Graduate School of Business. Richard Migliori is executive vice president of health services for UnitedHealth Group. He also serves as chief healthcare officer of UnitedHealth Group Alliances, a division of UnitedHealthcare Medicare and Retirement. Migliori joined UnitedHealth Group in 1996. He brings to his current executive position over 20 years of experience in the health care sector, including time as CEO of four diverse companies. He has published more than 35 articles on topics ranging from continuous quality improvement methods in a clinical setting to surgical oncology and solid organ transplant. Migliori holds an MD from Brown University and completed a National Health Research Fellowship in immunology, transplantation, and oncology funded by the National Institutes of Health.https://ssir.org/podcasts/entry/the_future_of_the_healthcare_sector

African Leadership Academy is a social enterprise that was founded in 2004 with the belief that ethical leadership is the key to transforming the African continent. In this university podcast, co-founder Chris Bradford talks about the role of educational institutions in shaping the future of Africa. He also discusses the personal journey that took him from Kalamazoo, Michigan, to Johannesburg, South Africa, and how Stanford was an influential part of that process. Bradford spoke at the 2011 Stanford Africa Forum: Entrepreneurship and Development, hosted by the Stanford Graduate School of Business.https://ssir.org/podcasts/entry/chris_bradford_education_as_social_enterprise_in_africa

Africa poses remarkable opportunities for private equity investment, according to Thomas Barry, founder of the Zephyr Management investment firm. Pointing to the reliability of its renewable resources, its growing workforce, its expanding urbanization, and other strengths critical for business success, he reveals that, on this continent, reality is much better than the US public perception. He also talks about his own firm’s investment strategy on the continent. Barry spoke at the 2011 Stanford Africa Forum on entrepreneurship and development.https://ssir.org/podcasts/entry/thomas_barry_investing_in_africa

Chairman Thomas Gibian talks about how he helped Emerging Capital Partners become the first private equity firm to raise more than $1.8 billion to invest in companies across the African continent through seven funds. He sets the stage by discussing how the private sector was the engine of growth in China and India, and shares how some of the lessons have been applied to Africa. He talks about where the growing markets are in the African continent, and the promising future for entrepreneurs there. Gibian spoke at the 2011 Stanford Africa Forum on entrepreneurship and development.https://ssir.org/podcasts/entry/thomas_gibian_private_equity_in_africa

How have the growing demands for “high-performance nonprofit” impacted some of the oldest philanthropic organizations in the United States? In this panel discussion, the CEOs of three organizations reflect upon the speed and tact with which they must adapt their strategies and directions in a new century. Peter Goldberg opens on the importance of fostering a culture of innovation, so that one might effectively bridge the gap between a “high touch” and a “high tech” strategy. Cathy Tisdale discusses both the value of having an iconic brand and the potential pitfalls of overextending legacy procedures. Jim Gibbons emphasizes the need for reinvention in nonprofit, such that you can remain relevant to the communities that you serve. Leadership 18 members Peter Goldberg, Cathy Tisdale, and Jim Gibbons were invited by the Center for Social Innovation’s Public Management Program and the Center for Leadership Development and Research at the Stanford Graduate School of Business. https://ssir.org/podcasts/entry/goldberg_tisdale_gibbons_leadership_trends_of_the_21st_century

Environmental sustainability is on President Obama’s agenda, and in this panel discussion we hear from senior government energy and technology officials on what’s up and coming in this area. Experts discuss the administration’s policies, programs, and initiatives to support clean energy innovation and entrepreneurship, in particular. The event was a panel discussion convened by the Stanford’s Steyer-Taylor Center for Energy Policy and Finance, a joint initiative of the Stanford Graduate School of Business and the Stanford Law School. https://ssir.org/podcasts/entry/clean_energy_dc2vc_environmental_sustainability_and_energy_policy

Biotechnology, diagnostics, and genomics are increasingly changing the field of healthcare. In this panel discussion, company executives discuss how they became entrepreneurs in science and medicine, which new products they are developing, and what challenges and opportunities there are in these arenas. They also look at barriers to adoption and future trends that will affect this space over the next five to ten years. The discussion was part of the 2011 Healthcare Summit, held at the Stanford Graduate School of Business. Donald Joseph, is CEO of BIO Ventures for Global Health (BVGH). BIO is the Biotechnology Industry Assocation. He previously served as COO for BVGH. Before joining BVGH, he served in senior executive positions in both legal and business roles at private and publicly held biopharmaceutical companies including Renovis and Abgenix, where he played a key role in its acquisition by Amgen. He has consulted for a number of biopharmaceutical companies and previously served as COO of the Institute for OneWorld Health, a non-profit pharmaceutical company devoted to developing new and affordable medicines for neglected diseases. David Levison is founder, CEO, and director of CardioDX. Prior to launching CardioDx, he was a venture partner at Texas Pacific Group Ventures and was also the interim CEO of Expression Diagnostics (XDx), Inc., a molecular diagnostic company focused on the immune system. Previously, he was the founder, president, and CEO of iScribe, a healthcare technology company acquired by AdvancePCS (now Caremark) in December 2001. Prior to iScribe, Levison was President of Oncology Therapeutics Network (OTN), which was acquired by Bristol-Myers Squibb in 1996. He also served as Chief Financial Officer of OTN’s parent company, Axion, from 1990 to 1993. Prior to Axion, Levison was with Cole Gilburne Fund, an early-stage, technology-focused venture capital firm. Bala Manian is a serial entrepreneur and Silicon Valley scientist who has started a string of medical technology companies such as ReaMetrix, Digital Optics, and Quantum Dot Corporation. Some of the resulting technologies have also had applications in the film industry, earning Manian an Academy Award certificate for technical achievement. James Sabry is vice president of Genentech Partnering. Prior to this, he was president and CEO of Arete Therapeutics as well as chairman and former CEO of Cytokinetics, a company he co-founded in August 1997. He currently sits on Cytokinetics’ scientific advisory board. Prior to Cytokinetics, he held faculty positions at the University of California, San Francisco, and Harvard Medical School. He serves on the board of HopeLab, a not-for-profit organization developing innovative technologies for the management of cancer, obesity, and other diseases. He received an M.D. from Queen’s University and a Ph.D. in neuroscience from the University of California, San Francisco. Robert Chess is chairman of Nektar Therapeutics, OPX Biotechnologies, and Germitec SAS. From March 2006 until January 2007, Chess served as acting president and CEO of Nektar, and from April 1999 to January 2007, served as executive chairman. He has also served as co-CEO, president, and CEO. He was previously the co-founder and president of Penederm, Inc., a publicly-traded dermatological pharmaceutical company that was sold to Mylan Laboratories. He has held management positions at Intel Corporation and Metaphor Computer Systems (now part of IBM), and was a member of the first President Bush’s White House staff as a White House Fellow and associate director of the White House Office of Economic and Domestic Policy.https://ssir.org/podcasts/entry/healthcare_and_biotechnology

Many would agree that healthcare delivery today is inefficient, ineffective, and segmented. In this panel discussion, experts talk about how they have persisted in delivering high-quality treatment. They discuss innovations in redesigning and scaling operations for wider benefit, the realities of implementation, and the need to train clinical workers in delivering compassionate care. The discussion was part of the 2011 Healthcare Summit, held at the Stanford Graduate School of Business. Gerald (Jerry) Coil is special assistant to the CMO, AltaMed Health Services. He has served as an internal consultant at AltaMed; senior consultant at Cattaneo & Stroud, Inc.; executive vice president and COO at HealthSpring; president and CEO at MHN; senior vice president at Health Net; senior vice president, benefit administration, at Kaiser Permanente; partner at NorthShore LLC; and regional vice president, Pacific Rim at North American Medical Management/Phycor. Thomas Lee is an MD with One Medical Group. He specializes in primary care internal medicine with an emphasis on preventive health, complex cases and quality improvement. Lee graduated from Yale University and the University of Washington School of Medicine, and completed his residency at Harvard’s Brigham and Women’s Hospital before serving as editor-in-chief for the widely used drug reference application Epocrates. He then founded One Medical Group as a step toward improving primary care delivery. Paul Wallace is director of the Lewin Center for Comparative Effectiveness Research. A board certified physician in internal medicine and hematology, he is a renowned lecturer on topics including evidence-based medicine practice and policy; performance improvement and measurement; clinical practice guideline development; population-based care and disease management; new technology assessment; and comparative assessment. He serves on advisory committees at the Institute of Medicine (IOM), and is a member of a number of healthcare-related boards. Arnold Milstein is professor of medicine and leader of Stanford University’s Clinical Excellence Research Center. His career and ongoing research are focused on acceleration of clinical service innovations that improve the societal value of health care. He serves as the medical director of the Pacific Business Group on Health, the largest regional health care improvement coalition in the U.S. He also guides employer-sponsored clinically-based innovation development for Mercer Health and Benefits. Previously he co-founded the Leapfrog Group and Consumer-Purchaser Disclosure Project, and served as a Congressionally-appointed MedPAC Commissioner.https://ssir.org/podcasts/entry/service_innovation

Behavior change is a step-by-step process, and psychologist and innovator Dr. BJ Fogg guides designers and researcher with “The Behavior Wizard,” which maps routes to the 15 ways to achieve behavior change. With specific health targets, whether it be to “eat quinoa for the first time” or “to stop smoking permanently,” his model outlines techniques to stop or decrease behaviors that are unhealthy or start or increase more healthful habits. Fogg is the Director of the Persuasive Technology Lab at Stanford and has taught the course Creating Health Habits with Social & Mobile Technologies, where students gained expertise in using technology to create habits in everyday people. He speaks in the 2011 Global Health Series organized by the Stanford Global Health Center in partnership with the Stanford Graduate School of Business.https://ssir.org/podcasts/entry/b.j._fogg_2011_stanford_healthcare_summit

The Jaquelin Hume Foundation engages in philanthropy by supporting free-market solutions to education reform. In this audio interview with Stanford Center for Social Innovation correspondent Ashkon Jafari, Executive Director Gisele Huff talks about the foundation’s investment strategy, and why innovation and technology initiatives are a big component of the organization’s giving. She also discusses education reform, what improvements the for-profit market can bring to K-12 education, and where the challenges to America’s school systems lie.https://ssir.org/podcasts/entry/gisele_huff_philanthropy_and_the_free_market_in_education

Four million babies die every year simply due to an inability to maintain their own body temperature. Incubators can save lives, but traditionally cost up to $20,000 and require a constant supply of electricity—prohibitive demands in many parts of the developing world. Leveraging the power of social entrepreneurship, Jane Chen and a team of her Stanford Graduate School of Business classmates developed Embrace, a portable and electricity-free alternative sold at about 0.1% of the cost of current incubators. In this audio lecture Chen discusses the challenges and rewards of the development process, and shares her insights on the attitudes that allow entrepreneurs to find success. Jane Chen was speaking as part of the annual Women in Management banquet organized by the Stanford Business School Alumni Association.https://ssir.org/podcasts/entry/jane_chen_solving_infant_mortality_with_social_entrepreneurship

We often find ourselves driven to consume unhealthy or damaging foods without fully understanding what motivates these cravings. In contrast with the predominantly physiological research in his field, the work of David Kessler contends that the fat, sugar, and salt in our foods are also capable of altering our brain’s chemistry in ways that drive these powerful compulsions. In this audio lecture he investigates the marketing strategies of multinational food companies and the ways in which they can exploit these habits. Former FDA Commissioner and author of the 2009 book The End of Overeating, David Kessler raises important questions about how we define the cultural norm for food consumption, what role our government should play in regulating food companies, and what ultimately is at stake for the United States. He stresses the difficulty in breaking our bad nutritional habits and still finding successful business alternatives. David Kessler was speaking as part of the Global Health Speaker Series organized by the Stanford Center on Global Health in partnership with the Stanford Graduate School of Business.https://ssir.org/podcasts/entry/david_kessler_food_industry_and_global_health